Live from the NIH registry
Studies recruiting near York right now
Top 25 of 448 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
WellSpan Health — York, Pennsylvania (0.3 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Penn State Health — Hershey, Pennsylvania (22.6 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Cancer Care Associates Of York /ID# 266143 — York, Pennsylvania (0.3 mi)
· Sponsor: AbbVie
Ultrasound Guided Serratus Anterior Plane Block for Rib Fractures
Rib Fracture Multiple
N/A
Interventional 60 participants sought
Wellspan Health York Hospital — York, Pennsylvania (0.3 mi)
· Sponsor: WellSpan Health
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Lancaster, Pennsylvania (23.1 mi)
· Sponsor: AstraZeneca
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Giselle Sholler
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Atherosclerosis, Cardiovascular Diseases
Phase 3
Interventional 252 participants sought
Heart and Vascular Research at WellSpan Health — York, Pennsylvania (0.3 mi)
· Sponsor: Eli Lilly and Company
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Cancer Care Associates of York (site 206) — York, Pennsylvania (0.3 mi)
· Sponsor: VM Oncology, LLC
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
Cancer Care Associates of York — York, Pennsylvania (0.3 mi)
· Sponsor: Gilead Sciences
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Lancaster General Hospital - Ann B Barshinger Cancer Institute — Lancaster, Pennsylvania (23.1 mi)
· Sponsor: Eli Lilly and Company
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Penn State Milton S Hershey Medical Ctr — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Janssen Research & Development, LLC
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Atopic Dermatitis (AD)
Phase 2
Interventional 105 participants sought
Enveda Investigative Site — Camp Hill, Pennsylvania (21.4 mi)
· Sponsor: Enveda Therapeutics
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Penn State Children's Hospital — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Children's Oncology Group
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Steba Biotech S.A.
FORWARD CAD IDE Study
Coronary Arterial Disease (CAD)
N/A
Interventional 408 participants sought
Wellspan York Hospital — York, Pennsylvania (0.3 mi)
· Sponsor: Shockwave Medical, Inc.
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Mantle Cell Lymphoma, B Cell Lymphoma
Phase 3
Interventional 300 participants sought
Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania (22.6 mi)
· Sponsor: BeOne Medicines
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Lancaster, Pennsylvania (23.1 mi)
· Sponsor: Alnylam Pharmaceuticals
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Osteosarcoma, Ewing Sarcoma
Phase 2
Interventional 406 participants sought
Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Milton S. Hershey Medical Center
Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis
Cholecystitis, Acute, Biliary Diseases
N/A
Interventional 90 participants sought
WellSpan Health York Hospital — York, Pennsylvania (0.3 mi)
· Sponsor: WellSpan Health
Reduction of Adverse Drug Events and Readmissions
Pharmacogenomic Testing for Medication Management
N/A
Observational 280,000 participants sought
MD@Home — York, Pennsylvania (0.3 mi)
· Sponsor: ClinLogic LLC
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
WellSpan Health-York Cancer Center — York, Pennsylvania (0.3 mi)
· Sponsor: SWOG Cancer Research Network
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
UPMC Pinnacle Harrisburg — Harrisburg, Pennsylvania (22.8 mi)
· Sponsor: SWOG Cancer Research Network
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Penn State Hershey — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Novartis Pharmaceuticals
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
Endometrial Cancer
N/A
Interventional 350 participants sought
Wellspan Health — York, Pennsylvania (0.3 mi)
· Sponsor: WellSpan Health
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Penn State Health Milton S. Hershey Medical Center — Hershey, Pennsylvania (22.6 mi)
· Sponsor: Regeneron Pharmaceuticals